{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/70842-225#drug","name":"Kimyrsa","alternateName":"oritavancin diphosphate","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"70842-225"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA214155"},{"@type":"PropertyValue","propertyID":"UNII","value":"VL1P93MKZN"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"5e755c40-6e73-4572-b474-4d8a131693d1"}],"activeIngredient":"ORITAVANCIN DIPHOSPHATE","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Melinta Therapeutics, LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA214155","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e755c40-6e73-4572-b474-4d8a131693d1","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70842-225"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-02T16:40:56.276Z"}}